Treatment Strategies for Uncommon EGFR Mutations in NSCLC

Panelists discuss the intricacies of treating uncommon EGFR mutations, dissecting approved treatment options, considerations for specific mutations, and insights into the evolving drug landscape.

Related Keywords

,Precision Medicine ,Biomarker Testing ,Nsclc ,Non Small Cell Lung Cancer ,Uncommon Egfr Mutations ,Egfr Mutations ,Egfr ,Egfr Mutation Classification ,Afatinib ,Osimertinib ,Mobocertinib ,Amivantamab ,Exon 20 Insertion Mutations ,Heymach Classification ,Mitki ,